Tumor-induced osteomalacia (TIO) is an ultrarare paraneoplastic syndrome due to
overproduction of fibroblast growth factor 23 (FGF23), with profound effects on patient …

Background X-linked hypophosphatemia (XLH) is an inherited disease of phosphate
metabolism in which inactivating mutations of the Phosphate Regulating Endopeptidase …

Abstract Tumour-induced osteomalacia (TIO), also known as oncogenic osteomalacia, is a
rare paraneoplastic disorder caused by tumours that secrete fibroblast growth factor 23 …

Tumor-induced osteomalacia (TIO) is a rare paraneoplastic syndrome caused by tumoral
production of fibroblast growth factor 23 (FGF23). The hallmark biochemical features include …

Tumor-induced osteomalacia (TIO) is a rare and largely underdiagnosed paraneoplastic
condition. Previous reviews often reported incomplete data on clinical aspects, diagnosis or …

Inorganic phosphate (Pi) is an abundant element in the body and is essential for a wide
variety of key biological processes. It plays an essential role in cellular energy metabolism …

Abstract Fibroblast growth factor 23 (FGF23) has emerged as an important regulator of
phosphate and vitamin D homeostasis. It is important to understand how FGF23 interacts …

Tumor‐induced osteomalacia (TIO) is an acquired form of hypophosphatemia. Tumor
resection leads to cure. We investigated the clinical characteristics of TIO, diagnostic …

Patients with tumor‐induced osteomalacia (TIO), an acquired paraneoplastic condition
characterized by osteomalacia due to hypophosphatemia, exhibit a similar clinical picture to …

Phosphate plays essential roles in many biological processes, and the serum phosphate
level is tightly controlled. Chronic hypophosphatemia causes impaired mineralization of the …